It can cause aplasticanemia and other effects on immune system cells.
2
Conclusions: Survivors of aplasticanemia are at high risk for subsequent malignant conditions.
3
The expression of these apoptotic genes was also investigated in aplasticanemia patients.
4
In conclusion, ALG-based IS therapy was effective for aplasticanemia in Chinese patients.
5
We examined whether mutations in the perforin gene occurred in acquired aplasticanemia.
1
Optimal treatment strategies for severe aplasticanaemia remain to be determined.
2
Then they were given the devastating diagnosis of aplasticanaemia.
3
We present here a patient treated for aplasticanaemia, who developed fungal arthritis of the hip and systemic candidaemia.
4
Aims: To review 10 years of local experience in treating severe aplasticanaemia with BMT and immunosuppressive therapy with emphasis on long-term outcomes.
5
These results suggest that while rIL-1 alpha can be safely administered, no significant haematologic improvement was observed in patients with severe aplasticanaemia.
6
In long-term use it carries a one in 30,000 risk of a serious side effect - the bone marrow disorder aplasticanaemia.